COMMUNIQUÉS West-GlobeNewswire

EssilorLuxottica entre au capital de Top Charoen pour renforcer sa présence en Thailande
02/04/2026
EssilorLuxottica entre au capital de Top Charoen pour renforcer sa présence en Thailande Paris, France et Bangkok, Thaïlande (2 avril 2026) – EssilorLuxottica et Top Charoen annoncent aujourd’hui la finalisation d’une [...]
EYLEA HD® (aflibercept) Approved by FDA as First and Only Injectable Anti-VEGF with Dosing Intervals Up to 5 Months for Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME)
02/04/2026
Approval is based on 96-week data from 2 pivotal trials showing majority of EYLEA HD patients maintained their visual and anatomic improvements with extended dosing intervals New EYLEA HD dosing regimen allows patients [...]
Liv Hospital Highlights Hospital-Based Stem Cell Infrastructure During Autism Awareness Month
02/04/2026
LivMedCell’s Ministry of Health-licensed cGMP framework supports physician-led evaluation and multidisciplinary clinical coordination Photo: Liv Hospital Ulus via FL Comms ISTANBUL, April 02, 2026 (GLOBE NEWSWIRE) -- [...]
AbbVie IBD Scholarship Program Marks 15 Years: Applications Open for 2026
02/04/2026
Celebrating 15 years of impact, the program supports Canadian students with Crohn’s disease or ulcerative colitis with fifteen $5,000 scholarships in 2026 TORONTO, April 02, 2026 (GLOBE NEWSWIRE) -- Crohn’s and Colitis [...]
Le programme de bourses d'études MII d’AbbVie fête ses 15 ans : les candidatures sont ouvertes pour 2026
02/04/2026
Depuis 15 ans, le programme soutient des étudiants canadiens atteints de la maladie de Crohn ou de colite ulcéreuse, en octroyant quinze bourses d'études de 5 000 $ TORONTO, 02 avr. 2026 (GLOBE NEWSWIRE) -- Crohn et [...]
BioCardia Files Request for Meeting With FDA to Discuss Accelerated Approval Pathway for CardiAMP® System in Ischemic Heart Failure
02/04/2026
SUNNYVALE, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today [...]
Visory Health Ranks Among Top U.S. Prescription Cards Providing Millions of Americans Access to Affordable Medications
02/04/2026
The discount card platform is disrupting a multi-billion-dollar industry in just four years ESTERO, Fla., April 02, 2026 (GLOBE NEWSWIRE) -- Visory Health , a patient-first health tech prescription platform that is [...]
Curonix LLC Announces Expanded Reimbursement Coverage for Freedom® Peripheral Nerve Stimulator (PNS) System, Providing Access To An Additional 27 Million Covered Lives Nationwide
02/04/2026
POMPANO BEACH, Fla., April 02, 2026 (GLOBE NEWSWIRE) -- Curonix LLC, a leading medical technology company dedicated to relieving chronic pain, today announced significant reimbursement milestones for its Freedom ® [...]
MIMEDX to Sponsor Leading Advanced Wound Care Conferences
02/04/2026
Multispecialty Focus with Industry Leadership Aimed at Improving Patient Outcomes Company Will Feature Recent Additions to Its Advanced Wound Care Portfolio MARIETTA, Ga., April 02, 2026 (GLOBE NEWSWIRE) -- MiMedx Group [...]
From Lab Fiber to Luxury Fabric: Kraig Biocraft Laboratories Targets Apparel First with Engineered Spider Silk
02/04/2026
DENVER, April 02, 2026 (GLOBE NEWSWIRE) -- ( www.247marketnews.com ) -- Kraig Biocraft Laboratories (OTCQB: KBLB) is advancing a transgenic silkworm platform designed to produce recombinant spider silk at commercial [...]
Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership
02/04/2026
Giannis becomes the first NBA athlete shareholder in a NASDAQ-listed health and longevity brand, joining the fastest supplement company ever to reach $100M ARR in just 11 months Giannis unlocks 35 million followers [...]
Sienna Announces First Quarter 2026 Results Release Date and Conference Call
02/04/2026
MARKHAM, Ontario, April 02, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) announced that it will report its 2026 first quarter results after market close on Tuesday, May 5 [...]
Protecting Healthy Futures: Unity Consortium Urges Families to Prioritize Adolescent Health During Immunization Action Week
02/04/2026
AIAW26 Runs April 6-10, Highlights the Critical Role of Well-Visits and AAP-Recommended Immunizations VENTNOR CITY, N.J., April 02, 2026 (GLOBE NEWSWIRE) -- Unity® Consortium, a non-profit dedicated to adolescent and [...]
Dr. Joseph Mikhael Steps into New Role as Medical Advisor for the International Myeloma Foundation
02/04/2026
STUDIO CITY, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today announced that Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO has taken the step of transitioning his role as Chief [...]
Entera Bio Announces Pricing of $10.0 Million Direct Investment by BVF Partners with Potential for up to $24.5 Million in Total Proceeds
02/04/2026
TEL AVIV, Israel, April 02, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (Nasdaq: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that it has entered into a securities [...]
Catalyst MedTech Announces Acquisition of X3D
02/04/2026
Expands OEM Platform and Strengthens Leadership in Nuclear Medicine Imaging PITTSBURGH, April 02, 2026 (GLOBE NEWSWIRE) -- Catalyst MedTech, a national leader in nuclear medicine and molecular imaging solutions, today [...]
PracticeLink Reveals Evolved Brand Identity Focused on Clarity, Simplicity and Trust for Healthcare Providers and Recruiters
02/04/2026
Updated identity reflects a clearer standard for what clinicians and hiring teams can expect—delivered steadily instead of disruptively ST. LOUIS and HINTON, West Virginia, April 02, 2026 (GLOBE NEWSWIRE) -- [...]
Ultragenyx Announces U.S. FDA Acceptance of BLA Resubmission for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)
02/04/2026
If approved, UX111 will be the first approved therapy for the treatment of Sanfilippo syndrome Type A, a rare disease affecting young children that leads to progressive, irreversible neurodegeneration and early death [...]
Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York
02/04/2026
CLEVELAND, April 02, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced activation of NewYork-Presbyterian/Columbia University Irving Medical Center in New York, NY as the newest Qualified [...]

Pages